Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs

Background: Selective serotonin reuptake inhibitors (SSRIs) are one of the most common drug classes leading to toxicity. The aim of this study was to evaluate the demographic characteristics, clinical symptoms, and treatment outcome of patients with SSRI poisoning.Methods: In this retrospective cros...

Full description

Bibliographic Details
Main Authors: Nastaran Eizadi-Mood, Narges Khademi, Shadi Haddad, maryam Ghasemi aliabadi, Parastoo Golshiri, Rokhsareh Meamar
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2022-12-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:https://jims.mui.ac.ir/article_26266_c41fffd2de3c15fb2250d847dfe53beb.pdf
_version_ 1797704077342146560
author Nastaran Eizadi-Mood
Narges Khademi
Shadi Haddad
maryam Ghasemi aliabadi
Parastoo Golshiri
Rokhsareh Meamar
author_facet Nastaran Eizadi-Mood
Narges Khademi
Shadi Haddad
maryam Ghasemi aliabadi
Parastoo Golshiri
Rokhsareh Meamar
author_sort Nastaran Eizadi-Mood
collection DOAJ
description Background: Selective serotonin reuptake inhibitors (SSRIs) are one of the most common drug classes leading to toxicity. The aim of this study was to evaluate the demographic characteristics, clinical symptoms, and treatment outcome of patients with SSRI poisoning.Methods: In this retrospective cross-sectional study, demographic, toxicological and clinical data were analyzed from the data of patients poisoned with SSRIs in 2019 in the referral poisoning emergency center of Khorshid Hospital affiliated with Isfahan University of Medical Sciences, Isfahan, Iran.Findings: Out of the 6631 poisoned emergency patients, 66 patients (1%) were hospitalized due to SSRI poisonings. The most common poisoning drug was citalopram (39.4%) followed by sertraline (37.9%). The mean age of patients was 25.9 years and most of them were women (90.9%) with intentional poisoning (78.8%). Nausea and vomiting (43.9%) were the most common clinical symptoms. 20 patients (30.3%) had sinus tachycardia, which was mostly related to sertraline (26.7%). Two patients (3%) had seizures with citalopram and only one patient had serotonin toxicity following citalopram ingestion. The mean length of hospital stay was 0.56±1.54. None of the factors investigated was a good predictor for the duration of hospital stay duration.Conclusion: In this study, the most common SSRIs causing poisoning were citalopram, followed by sertraline. All patients were discharged with supportive measures and with complete recovery, but in order to evaluate the effects of poisoning of these drugs, there is a need for studies in longer periods of time and with larger sample size.
first_indexed 2024-03-12T05:14:02Z
format Article
id doaj.art-badf1450154540b5b8f122e1fe53aa0e
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T05:14:02Z
publishDate 2022-12-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-badf1450154540b5b8f122e1fe53aa0e2023-09-03T08:22:20ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2022-12-014069285786410.48305/jims.v40.i692.085726266Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor DrugsNastaran Eizadi-Mood0Narges Khademi1Shadi Haddad2maryam Ghasemi aliabadi3Parastoo Golshiri4Rokhsareh Meamar5Professor, Department of Clinical Toxicology, Isfahan Clinical Toxicology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranGeneral Physician, Department of Clinical Toxicology, School of Medicine, Isfahan Clinical Toxicology Research Center, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, IranGeneral Physician, Department of Clinical Toxicology, School of Medicine, Isfahan Clinical Toxicology Research Center, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, IranGeneral Physician, Department of Clinical Toxicology, School of Medicine, Isfahan Clinical Toxicology Research Center, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Department of Community and Preventive Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Department of Clinical Toxicology, School of Medicine, Isfahan Clinical Toxicology Research Center, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, IranBackground: Selective serotonin reuptake inhibitors (SSRIs) are one of the most common drug classes leading to toxicity. The aim of this study was to evaluate the demographic characteristics, clinical symptoms, and treatment outcome of patients with SSRI poisoning.Methods: In this retrospective cross-sectional study, demographic, toxicological and clinical data were analyzed from the data of patients poisoned with SSRIs in 2019 in the referral poisoning emergency center of Khorshid Hospital affiliated with Isfahan University of Medical Sciences, Isfahan, Iran.Findings: Out of the 6631 poisoned emergency patients, 66 patients (1%) were hospitalized due to SSRI poisonings. The most common poisoning drug was citalopram (39.4%) followed by sertraline (37.9%). The mean age of patients was 25.9 years and most of them were women (90.9%) with intentional poisoning (78.8%). Nausea and vomiting (43.9%) were the most common clinical symptoms. 20 patients (30.3%) had sinus tachycardia, which was mostly related to sertraline (26.7%). Two patients (3%) had seizures with citalopram and only one patient had serotonin toxicity following citalopram ingestion. The mean length of hospital stay was 0.56±1.54. None of the factors investigated was a good predictor for the duration of hospital stay duration.Conclusion: In this study, the most common SSRIs causing poisoning were citalopram, followed by sertraline. All patients were discharged with supportive measures and with complete recovery, but in order to evaluate the effects of poisoning of these drugs, there is a need for studies in longer periods of time and with larger sample size.https://jims.mui.ac.ir/article_26266_c41fffd2de3c15fb2250d847dfe53beb.pdfssridemographypoisoningcritical care outcomesdrug-related side effects and adverse reactions
spellingShingle Nastaran Eizadi-Mood
Narges Khademi
Shadi Haddad
maryam Ghasemi aliabadi
Parastoo Golshiri
Rokhsareh Meamar
Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
مجله دانشکده پزشکی اصفهان
ssri
demography
poisoning
critical care outcomes
drug-related side effects and adverse reactions
title Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
title_full Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
title_fullStr Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
title_full_unstemmed Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
title_short Demographic Factors, Clinical Manifestations and Treatment Outcomes in Patients Poisoned with Selective Serotonin Reuptake Inhibitor Drugs
title_sort demographic factors clinical manifestations and treatment outcomes in patients poisoned with selective serotonin reuptake inhibitor drugs
topic ssri
demography
poisoning
critical care outcomes
drug-related side effects and adverse reactions
url https://jims.mui.ac.ir/article_26266_c41fffd2de3c15fb2250d847dfe53beb.pdf
work_keys_str_mv AT nastaraneizadimood demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs
AT nargeskhademi demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs
AT shadihaddad demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs
AT maryamghasemialiabadi demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs
AT parastoogolshiri demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs
AT rokhsarehmeamar demographicfactorsclinicalmanifestationsandtreatmentoutcomesinpatientspoisonedwithselectiveserotoninreuptakeinhibitordrugs